Scott L. Dax

1.4k citations

50 papers · 1.1k indexed · h-index 19

Organic Chemistry top 5%
Molecular Biology
Cellular and Molecular Neuroscience top 10%
Sensory Systems top 2%
Physiology

Co-authors: Mark A. Youngman James J. McNally Joseph P. Marino Sui‐Po Zhang Adrienne E. Dubin Ellen E. Codd Nadia Nasser Mark E. McDonnell
Topics: Ion Channels and Receptors (10 papers)Neuropeptides and Animal Physiology (8 papers)Pain Mechanisms and Treatments (7 papers)
Cited by: Sensory Systems Organic Chemistry Toxicology
Journals: The FASEB Journal Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States Switzerland India

In The Last Decade

Scott L. Dax

50 papers receiving 1.0k citations

Peers

Countries citing papers authored by Scott L. Dax

Since Specialization

Citations

This map shows the geographic impact of Scott L. Dax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott L. Dax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott L. Dax more than expected).

Fields of papers citing papers by Scott L. Dax

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott L. Dax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott L. Dax. The network helps show where Scott L. Dax may publish in the future.

Co-authorship network of co-authors of Scott L. Dax

This figure shows the co-authorship network connecting the top 25 collaborators of Scott L. Dax. A scholar is included among the top collaborators of Scott L. Dax based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott L. Dax. Scott L. Dax is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers 2014 ·British Journal of Anaesthesia ·James F. McLeod,J. Leempoels,Shuying Peng,Scott L. Dax,(unknown),Francis J. Golder	27
2	Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists 2013 ·Bioorganic & Medicinal Chemistry Letters ·Bin Zhu,Mingde Xia,(unknown),Donald Ludovici,Manomi A. Tennakoon,Mark A. Youngman,Jay M. Matthews,Scott L. Dax,Raymond W. Colburn,Na Qin,Tasha L. Hutchinson,Mary Lou Lubin,Michael R. Brandt,Dennis J. Stone,Christopher M. Flores,Mark J. Macielag	24
3	The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·Jay M. Matthews,Na Qin,Raymond W. Colburn,Scott L. Dax,Mike F. Hawkins,James J. McNally,(unknown),Mark A. Youngman,Judith F. Baker,Tasha L. Hutchinson,Yi Liu,Mary Lou Lubin,Michael P. Neeper,Michael R. Brandt,Dennis J. Stone,Christopher M. Flores	28
4	N-Pyridin-3-yl- and N-quinolin-3-yl-benzamides: Modulators of Human Vanilloid Receptor 1 (TRPV1) 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),James J. McNally,Mark A. Youngman,Mark E. McDonnell,Adrienne E. Dubin,Nadia Nasser,Sui‐Po Zhang,Ellen E. Codd,(unknown),(unknown),Michael R. Brandt,Christopher M. Flores,Scott L. Dax	4
5	Heteroaryl β-tetralin ureas as novel antagonists of human TRPV1 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Mark A. Youngman,James J. McNally,Mark E. McDonnell,Sui‐Po Zhang,Adrienne E. Dubin,Nadia Nasser,Ellen E. Codd,Christopher M. Flores,Scott L. Dax	18
6	The Novel, Orally Active, Delta Opioid RWJ-394674 Is Biotransformed to the Potent Mu Opioid RWJ-413216 2006 ·Journal of Pharmacology and Experimental Therapeutics ·E E Codd,John R. Carson,Raymond W. Colburn,Scott L. Dax,Daksha Desai‐Krieger,Rebecca P. Martinez,L. A. McKown,(unknown),Philip Pitis,(unknown),Dennis J. Stone,Anthony J. Streeter,W. N. Wu,Sui‐Po Zhang	14
7	N , N -Dialkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, potent, selective δ opioid agonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·John R. Carson,Steven J. Coats,Ellen E. Codd,Scott L. Dax,Jung Lee,Rebecca P. Martinez,(unknown),Philip Pitis,Sui‐Po Zhang	18
8	Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Steven J. Coats,Mark J. Schulz,John R. Carson,Ellen E. Codd,Dennis J. Hlasta,Philip Pitis,Dennis J. Stone,Sui‐Po Zhang,(unknown),Scott L. Dax	20
9	N-Isoquinolin-5-yl-N′-aralkyl-urea and -amide antagonists of human vanilloid receptor 1 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Mark A. Youngman,James J. McNally,Sui‐Po Zhang,Adrienne E. Dubin,Nadia Nasser,Scott L. Dax	18
10	Novel non-peptidic neuropeptide Y Y 2 receptor antagonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Jill A. Jablonowski,Wenying Chai,Xiaobing Li,(unknown),William V. Murray,Mark A. Youngman,Scott L. Dax,Diane Nepomuceno,Pascal Bonaventure,Timothy W. Lovenberg,Nicholas I. Carruthers	17
11	N -Alkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, μ and δ opioid agonists: a μ address 2004 ·Bioorganic & Medicinal Chemistry Letters ·John R. Carson,Steven J. Coats,Ellen E. Codd,Scott L. Dax,Jung Lee,Rebecca P. Martinez,L. A. McKown,(unknown),Philip Pitis,(unknown),Sui‐Po Zhang	6
12	Synthesis and structure–Activity relationships of aroylpyrrole alkylamide bradykinin (B2) antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Mark A. Youngman,John R. Carson,(unknown),Scott L. Dax,Sui‐Po Zhang,(unknown),Dennis J. Stone,Ellen E. Codd,(unknown)	4
13	7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1 2003 ·Bioorganic & Medicinal Chemistry Letters ·Mark E. McDonnell,(unknown),Nadia Nasser,Adrienne E. Dubin,Scott L. Dax	16
14	Design and synthesis of novel pyrrolidine-containing bradykinin antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Jung Eun Lee,Charles H. Reynolds,(unknown),Mark A. Youngman,Dennis J. Hlasta,Scott L. Dax,Dennis J. Stone,Sui‐Po Zhang,Ellen E. Codd	11
15	Aminopyrazoles with high affinity for the human neuropeptide Y5 receptor 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Chi Luo,Brian C. Zanoni,Scott L. Dax,James J. McNally,Timothy W. Lovenberg,Sandy J. Wilson,Allen B. Reitz	27
16	N-(Sulfonamido)alkyl[tetrahydro-1H-benzo[e]indol-2-yl]amines: potent antagonists of human neuropeptide Y Y5 receptor 2000 ·Bioorganic & Medicinal Chemistry Letters ·James J. McNally,Mark A. Youngman,Timothy W. Lovenberg,Diane Nepomuceno,Sandy J. Wilson,Scott L. Dax	17
17	N-Acylated α-(3-pyridylmethyl)-β-aminotetralin antagonists of the human neuropeptide Y Y5 receptor 2000 ·Bioorganic & Medicinal Chemistry Letters ·James J. McNally,Mark A. Youngman,Timothy W. Lovenberg,Diane Nepomuceno,Sandy Wilson,Scott L. Dax	13
18	Dual-action penems and carbapenems 1992 ·Journal of Medicinal Chemistry ·(unknown),Scott L. Dax,Norma Dunlap,N H Georgopapadakou,Dennis D. Keith,David L. Pruess,(unknown),Rudolf Then,(unknown),(unknown)	35
19	Indoloquinones from azomethine ylides via the 4-oxazoline route 1989 ·Tetrahedron Letters ·Edwin Vedējs,Scott L. Dax	11
20	Synthesis and rearrangements of ortho-selenonium phenoxides 1987 ·Tetrahedron Letters ·Joseph P. Marino,Scott L. Dax	5

About Scott L. Dax

Scott L. Dax is a scholar working on Sensory Systems, Endocrine and Autonomic Systems and Toxicology, having authored 50 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ion Channels and Receptors (10 papers), Neuropeptides and Animal Physiology (8 papers) and Pain Mechanisms and Treatments (7 papers). The work is most often cited by research in Sensory Systems (222 citations), Organic Chemistry (493 citations) and Toxicology (55 citations). Scott L. Dax has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Mark A. Youngman, James J. McNally, Joseph P. Marino, Sui‐Po Zhang, Adrienne E. Dubin, Ellen E. Codd, Nadia Nasser, Mark E. McDonnell, Dennis J. Stone and Timothy W. Lovenberg. Their work appears in journals such as The FASEB Journal, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact